Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 37,384 followers.

@FrontImmunol RT: New Research: Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis: Objective The monoclonal anti-PD-1 antibodies nivolumab and pembrolizumab are the first immune checkpoint inhibitors… https://t.co/ISdyYkEl9U #immun

11 Aug 2021

Reply Repost Favourite

New Research: Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis: Objective The monoclonal antibodies anti-programmed death protein-1 (anti–PD-1) nivolumab and pembrolizumab are the first immune checkpoint inhibitors… https://t.co/1U

09 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.